Skip to main content
PLOS One logoLink to PLOS One
. 2026 Mar 30;21(3):e0344554. doi: 10.1371/journal.pone.0344554

Maternal smoking behaviour during pregnancy and the association of Sudden Unexpected Infant Death (SUID): A retrospective cohort study of births in the United States from 2017–2021

Kiki Hudson 1,2,*,#, Giulia M Muraca 1,2,#
Editor: Malshani Lakshika Pathirathna3
PMCID: PMC13035152  PMID: 41911268

Abstract

Background

Maternal smoking during pregnancy is a significant risk factor for sudden unexpected infant death (SUID). However, the impact of variations in smoking behaviours, including timing, intensity, and cessation, remains understudied. This study examines the association between maternal smoking and SUID, incorporating detailed categorizations of smoking behaviours.

Methods

We conducted a population-based, retrospective cohort study of live births in the United States from 2017 to 2021 using the Centre for Disease Control Linked Birth-Infant Death files. Maternal smoking was categorized as non-smoking, pre-pregnancy smoking only, trimester-specific smoking, continuous or discontinuous smoking, and cessation before the third trimester, with stratification by smoking intensity. SUID was defined using ICD-10 codes. Multivariable logistic regression was used to estimate unadjusted (OR) and adjusted odds ratios (aOR) for SUID. Sensitivity analyses examined mediation by gestational age and infant birth weight.

Results

Heavy continuous smokers had the highest aOR for SUID (372.8 per 100,000 births; aOR 2.81, 95% CI 2.67–2.94), followed by light continuous smokers (395.6 per 100,000 births; aOR 2.47, 95% CI 2.19–2.78) and discontinuous heavy smokers (292.5 per 100,000 births; aOR 2.29, 95% CI 1.72–3.00) compared with non-smokers. Pre-pregnancy-only smokers had the lowest odds of SUID among all smoking categories (light: 188.2 per 100,000 births; aOR 1.77, 95% CI 1.48–2.10; heavy: 152.8 per 100,000 births; aOR 1.61, 95% CI 1.44–1.78). In the sensitivity analysis, the natural indirect effect (NIE) of continuous smoking throughout pregnancy on SUID through gestational age and infant birth weight were insignificant (gestational age: β = 1.01, 95% CI 0.99–1.03, p = 0.28, infant birth weight: β = 1.04, 95% CI 0.99–1.08, p = 0.10).

Conclusions

Maternal smoking significantly influences SUID, with earlier cessation exhibiting weaker associations. These findings emphasize the importance of early smoking cessation interventions to improve SUID outcomes.

Introduction

Sudden Unexpected Infant Death (SUID) is the combination of primarily sleep-related deaths during infancy that are due to (1) sudden infant death syndrome (SIDS), (2) accidental suffocation or strangulation in bed (or any other location), and (3) ill-defined or other unknown causes [1,2]. It is the most common cause of infant mortality between one month and one year of age in high-income countries [1,3]. Recent estimates of SUID incidence in the United States (US) are between 90 and 100 deaths per 100,000 live births [4,5]. The most important risk factors for SUID are related to the sleep environment, with sleep position, bed-sharing with a parent, and soft sleeping surface being particularly critical [1]. Another important risk factor for SIDS is maternal smoke exposure [1]. This risk is most significant for maternal smoking while pregnant, but maternal smoking after birth and higher general tobacco exposure also increase the risk of SUID [6,7]. Studies have reported a fourfold greater risk of SUID among mothers who smoked during pregnancy compared to mothers who did not smoke [8]. Other known risk factors include young maternal age, no or poor prenatal care, prematurity, low infant birth weight, male sex, and maternal mental illness and substance abuse [1,9–14].

Over the last 20 years, the incidence of SUID has decreased by more than 50%. This has been largely credited to the efforts of the Back to Sleep campaign, a public health initiative promoting a safe infant sleeping environment [1]. However, SUID attributable to maternal smoking remains significant and preventable. In the US, approximately 3700 infants die annually from SUID, among which 22% can be attributed to smoking [15]. Previous studies characterizing the association between maternal smoking during pregnancy and SUID are limited by their definitions of maternal smoking, preventing assessment of the impact of distinct smoking behaviours, such as continuous smoking versus changes in smoking behaviours throughout pregnancy [15,16]. Furthermore, prior studies have not examined the impact of potential mediators such as prematurity and low infant birth weight on the association between maternal smoking and SUID. Lastly, several important confounders have not been accounted for in previous studies, including maternal obesity, pre-pregnancy hypertension, mother’s nativity, and payment source for delivery [17,18]. Accounting for these covariates is crucial because they capture important social, biological, and structural determinants of health that could confound or modify the observed association between maternal smoking and SUID. Therefore, to effectively address the ongoing issue of SUID, a more nuanced approach is needed.

Our objective was to assess the association between maternal smoking behaviour and SUID using seven categories of maternal smoking behaviour measurement: 1) no smoking, 2) smoking prior to pregnancy, 3) only smoked during the first trimester, 4) only smoked during the second or third trimester, 5) continuous smoking throughout pregnancy 6) discontinuous smoking throughout pregnancy, 7) smoking cessation during pregnancy. Additionally, we assessed the presence of a dose response in the relationship between maternal smoking and SUID through further categorization into heavy and light smokers for each maternal smoking behaviour.

Methods

Study design and data source

We used the Centers for Disease Control and Prevention (CDC) linked Birth-Infant Death Files to carry out a population-based cohort study of births in the US from 2017 to 2021 [19]. These data sets link infant death records with corresponding birth records, allowing for detailed analyses of maternal, pregnancy, and infant characteristics.

Study population

The study included singleton, live births in the US occurring between January 1, 2017, and December 31, 2021, and infant deaths within the first year of life. Low birth weight is known to be highly associated with child mortality; thus, birth weights of less than 1000 grams were excluded to limit the effects of extremely low birth weights [20]. Furthermore, gestational ages of less than 25 weeks were excluded to limit extreme prematurity and to ensure all gestational ages reach at least one week into the third trimester. Infants with congenital anomalies were also excluded. Further exclusions were applied to missing data on exposure, outcome, or confounders and mediators, ensuring complete data for analysis (Fig 1).

Fig 1. Derivation of complete case cohort.

Fig 1

Exposure and outcome definitions

The primary exposure was maternal smoking behaviour, categorized into seven groups: 1) no pre-pregnancy and prenatal smoking, 2) only pre-pregnancy smoking, 3) only smoked during the first trimester, 4) only smoked during the second or third trimester, 5) continuous smoking (smoking during pre-pregnancy and throughout pregnancy or smoking throughout the three trimesters), 6) discontinuous smoking (stopped smoking during any period of time throughout pregnancy and started smoking again at a later time in their pregnancy), and 7) smoking cessation (continuous smoking during pre-pregnancy and through multiple trimesters and stopped before their third trimester). To calculate dose response, each of the smoking categories were further categorized into heavy and light smokers. Participants that smoked on average 20 cigarettes or more per day were considered heavy smokers and those that smoke on average less than 20 cigarettes per day were considered light smokers [21].

The outcome of interest was SUID, defined as the death of an infant under 365 days old, due to the following causes and corresponding ICD-10 codes, Sudden Infant Death Syndrome (R95), ill-defined and unknown causes (R99), or accidental suffocation and strangulation in bed (W75) [15].

Covariates

Covariates included in our analysis were determined a priori based on previous studies [15–18]. Socioeconomic status (SES) variables including maternal ethnicity, marital status, maternal education, maternal nativity, Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), and payment method. Maternal characteristics including maternal age, pre-pregnancy body mass index, pregnancy weight gain, pre-pregnancy hypertension, and gestational hypertension. Other pregnancy characteristics including total pregnancy order, number of prenatal visits, and prior terminations or fetal death. Lastly, gestational age and infant birth weight have been identified as potential mediators based on their previously established associations with maternal smoking and SUID [22–24].

Statistical analysis

Descriptive statistics on demographics and clinical characteristics of individuals with live births in the US were calculated for the study cohort and stratified by maternal smoking behaviour categories. We estimated crude SUID rates per 100,000 live births within each smoking behaviour category. Multivariable logistic regression models were used to estimate unadjusted and adjusted odds ratios (ORs) for the association between maternal smoking behaviour categories and SUID, comparing each maternal smoking behaviour to the no pre-pregnancy and prenatal smoking category, and controlling for previously determined confounders.

Sensitivity analysis

Mediation analysis was carried out to investigate the roles of gestational age and infant birth weight as mediators in the relationship between maternal smoking behaviour and SUID. Gestational age and infant birth weight were categorized into binary variables. Gestational age under 37 weeks were categorized as preterm and infant birth weight under 2500 grams were categorized as “low” [24]. All mediation analysis examined the controlled direct effect (CDE; variable of interest effect on the outcome when the mediator is set to a fixed level), natural indirect effect (NIE; variable of interest effect on the outcome that is influenced by the mediator variable), natural direct effect (NDE; effect on the outcome after adjusting for the indirect effect exerted by the mediator), and total effect (overall variable of interest effect on the outcome, equal to NDE  +  NIE) [25].

Results

There were 18,713,624 live births in the US between 2017 and 2021. After applying the exclusion criteria, the study population included 16,484,245 live births from 2017–2021 Demographics are outlined in detail in Table 1. Of the total population, 92% of patients were non-smokers (n = 15,222,196), 4% were heavy smokers who continuously smoked during their pregnancy (n = 664,741), 1.4% were heavy smokers who only smoked during pre-pregnancy (n = 234,259), and 0.94% were heavy smokers who ceased smoking before their third trimester (n = 154,618). The remaining maternal smoking behaviour groups (first trimester only heavy and light smokers, second or third trimester only heavy and light smokers, continuous light smokers, discontinuous heavy and light smokers, pre-pregnancy only light smokers, and smoking cessation light smokers) each represent less than 0.5% of the total population (Table 1).

Table 1. Demographic and maternal smoking behaviour of individuals with live births in the United States, 2017–2021.

Maternal smoking behaviour throughout pregnancy
Overall N = 16,484,245 Nonsmoker N = 15,222,196 1st Trimester Light N = 1,980 Pre-pregnancy Only Heavy N = 234,259 Pre-pregnancy Only Light N = 69,620 Smoking Cessation Heavy N = 154,618 2nd or 3rd Trimester Heavy N = 4,406 Smoking Cessation Light N = 33,362 Discontinuous Smoking Heavy N = 17,096 1st Trimester Heavy N = 3,692 Continuous Smoking Heavy N = 664,741 Continuous Smoking Light N = 71,790 Discontinuous Smoking Light N = 4,067 2nd or 3rd Trimester Light N = 2,418
SUID
No 16,470,181 (100%) 15,211,987 (100%) 1,977 (100%) 233,901 (100%) 69,489 (100%) 154,217 (100%) 4,394 (100%) 33,269 (100%) 17,046 (100%) 3,679 (100%) 662,263 (100%) 71,506 (100%) 4,047 (100%) 2,406 (100%)
Yes 14,064 (<0.1%) 10,209 (<0.1%) 3 (0.2%) 358 (0.2%) 131 (0.2%) 401 (0.3%) 12 (0.3%) 93 (0.3%) 50 (0.3%) 13 (0.4%) 2,478 (0.4%) 284 (0.4%) 20 (0.5%) 12 (0.5%)
Maternal Race
White 12,211,626 (74%) 11,192,488 (74%) 1,182 (60%) 190,557 (81%) 49,051 (70%) 124,881 (81%) 3,215 (73%) 21,079 (63%) 13,802 (81%) 2,648 (72%) 562,796 (85%) 45,921 (64%) 2,567 (63%) 1,439 (60%)
Black 2,546,115 (15%) 2,393,199 (16%) 583 (29%) 26,628 (11%) 13,123 (19%) 17,945 (12%) 812 (18%) 8,418 (25%) 1,870 (11%) 703 (19%) 61,943 (9.3%) 19,190 (27%) 1,000 (25%) 701 (29%)
American Indian and Alaska Native 155,263 (0.9%) 130,869 (0.9%) 75 (3.8%) 3,508 (1.5%) 2,168 (3.1%) 2,828 (1.8%) 122 (2.8%) 1,304 (3.9%) 392 (2.3%) 102 (2.8%) 11,184 (1.7%) 2,394 (3.3%) 203 (5.0%) 114 (4.7%)
Asian 1,077,222 (6.5%) 1,068,316 (7.0%) 39 (2.0%) 2,689 (1.1%) 1,451 (2.1%) 1,166 (0.8%) 41 (0.9%) 461 (1.4%) 70 (0.4%) 73 (2.0%) 2,182 (0.3%) 678 (0.9%) 28 (0.7%) 28 (1.2%)
Native Hawaiian or Other Pacific Islander 50,363 (0.3%) 48,025 (0.3%) 5 (0.3%) 507 (0.2%) 237 (0.3%) 309 (0.2%) 18 (0.4%) 104 (0.3%) 34 (0.2%) 11 (0.3%) 906 (0.1%) 182 (0.3%) 18 (0.4%) 7 (0.3%)
More than one 443,656 (2.7%) 389,299 (2.6%) 96 (4.8%) 10,370 (4.4%) 3,590 (5.2%) 7,489 (4.8%) 198 (4.5%) 1,996 (6.0%) 928 (5.4%) 155 (4.2%) 25,730 (3.9%) 3,425 (4.8%) 251 (6.2%) 129 (5.3%)
Maternal Education
8th grade or less 499,811 (3.0%) 480,184 (3.2%) 54 (2.7%) 1,659 (0.7%) 733 (1.1%) 1,444 (0.9%) 104 (2.4%) 426 (1.3%) 238 (1.4%) 62 (1.7%) 13,332 (2.0%) 1,455 (2.0%) 74 (1.8%) 46 (1.9%)
9th through 12th grade with no diploma 1,481,857 (9.0%) 1,234,827 (8.1%) 428 (22%) 27,412 (12%) 8,974 (13%) 24,261 (16%) 1,110 (25%) 6,211 (19%) 3,480 (20%) 767 (21%) 155,398 (23%) 17,504 (24%) 854 (21%) 631 (26%)
High school graduate or GED completed 4,269,930 (26%) 3,735,290 (25%) 814 (41%) 90,326 (39%) 24,700 (35%) 64,714 (42%) 1,883 (43%) 13,583 (41%) 7,383 (43%) 1,598 (43%) 295,909 (45%) 31,044 (43%) 1,705 (42%) 981 (41%)
Some college credit, but not a degree 3,238,307 (20%) 2,923,977 (19%) 471 (24%) 69,550 (30%) 20,186 (29%) 44,178 (29%) 896 (20%) 8,969 (27%) 4,367 (26%) 855 (23%) 147,854 (22%) 15,463 (22%) 998 (25%) 543 (22%)
Associate degree 1,390,978 (8.4%) 1,310,419 (8.6%) 118 (6.0%) 20,955 (8.9%) 5,701 (8.2%) 11,228 (7.3%) 259 (5.9%) 2,204 (6.6%) 1,040 (6.1%) 229 (6.2%) 34,646 (5.2%) 3,796 (5.3%) 255 (6.3%) 128 (5.3%)
Bachelor’s degree 3,502,385 (21%) 3,449,926 (23%) 74 (3.7%) 18,965 (8.1%) 6,994 (10%) 7,163 (4.6%) 116 (2.6%) 1,588 (4.8%) 484 (2.8%) 138 (3.7%) 14,697 (2.2%) 2,039 (2.8%) 140 (3.4%) 61 (2.5%)
Master’s degree 1,625,905 (9.9%) 1,614,376 (11%) 17 (0.9%) 4,689 (2.0%) 1,973 (2.8%) 1,408 (0.9%) 26 (0.6%) 319 (1.0%) 87 (0.5%) 33 (0.9%) 2,498 (0.4%) 422 (0.6%) 34 (0.8%) 23 (1.0%)
Doctorate or Professional Degree 475,072 (2.9%) 473,197 (3.1%) 4 (0.2%) 703 (0.3%) 359 (0.5%) 222 (0.1%) 12 (0.3%) 62 (0.2%) 17 (<0.1%) 10 (0.3%) 407 (<0.1%) 67 (<0.1%) 7 (0.2%) 5 (0.2%)
WIC
No 10,903,059 (66%) 10,317,631 (68%) 875 (44%) 129,303 (55%) 37,508 (54%) 73,756 (48%) 1,926 (44%) 15,001 (45%) 7,152 (42%) 1,698 (46%) 283,716 (43%) 31,695 (44%) 1,729 (43%) 1,069 (44%)
Yes 5,581,186 (34%) 4,904,565 (32%) 1,105 (56%) 104,956 (45%) 32,112 (46%) 80,862 (52%) 2,480 (56%) 18,361 (55%) 9,944 (58%) 1,994 (54%) 381,025 (57%) 40,095 (56%) 2,338 (57%) 1,349 (56%)
Number of Prenatal Visits
0-6 visits 1,629,431 (9.9%) 1,408,561 (9.3%) 380 (19%) 20,174 (8.6%) 7,781 (11%) 19,731 (13%) 1,036 (24%) 5,877 (18%) 2,857 (17%) 559 (15%) 143,300 (22%) 17,762 (25%) 787 (19%) 626 (26%)
7-10 visits 4,969,577 (30%) 4,593,786 (30%) 635 (32%) 64,082 (27%) 20,749 (30%) 45,784 (30%) 1,366 (31%) 10,539 (32%) 5,203 (30%) 1,128 (31%) 201,847 (30%) 22,397 (31%) 1,285 (32%) 776 (32%)
11-14 visits 7,344,295 (45%) 6,858,077 (45%) 694 (35%) 107,983 (46%) 30,130 (43%) 64,467 (42%) 1,447 (33%) 12,626 (38%) 6,678 (39%) 1,428 (39%) 235,044 (35%) 23,479 (33%) 1,512 (37%) 730 (30%)
15 visits and over 2,540,942 (15%) 2,361,772 (16%) 271 (14%) 42,020 (18%) 10,960 (16%) 24,636 (16%) 557 (13%) 4,320 (13%) 2,358 (14%) 577 (16%) 84,550 (13%) 8,152 (11%) 483 (12%) 286 (12%)
Gestation
under 37 weeks 1,574,357 (9.6%) 1,412,529 (9.3%) 284 (14%) 22,035 (9.4%) 6,696 (9.6%) 18,026 (12%) 647 (15%) 4,185 (13%) 1,804 (11%) 435 (12%) 95,756 (14%) 11,120 (15%) 479 (12%) 361 (15%)
37-38 weeks 4,322,595 (26%) 3,979,105 (26%) 497 (25%) 59,687 (25%) 17,707 (25%) 39,504 (26%) 1,235 (28%) 8,830 (26%) 4,691 (27%) 936 (25%) 188,379 (28%) 20,284 (28%) 1,086 (27%) 654 (27%)
39-40 weeks 8,433,504 (51%) 7,849,221 (52%) 915 (46%) 118,393 (51%) 34,875 (50%) 74,128 (48%) 1,933 (44%) 15,490 (46%) 8,096 (47%) 1,787 (48%) 294,504 (44%) 31,211 (43%) 1,912 (47%) 1,039 (43%)
41 weeks and over 2,153,789 (13%) 1,981,341 (13%) 284 (14%) 34,144 (15%) 10,342 (15%) 22,960 (15%) 591 (13%) 4,857 (15%) 2,505 (15%) 534 (14%) 86,102 (13%) 9,175 (13%) 590 (15%) 364 (15%)
Infant Birth Weight
1000-2499 grams 972,814 (5.9%) 844,796 (5.5%) 183 (9.2%) 13,923 (5.9%) 4,410 (6.3%) 12,940 (8.4%) 480 (11%) 3,128 (9.4%) 1,365 (8.0%) 295 (8.0%) 81,687 (12%) 8,961 (12%) 371 (9.1%) 275 (11%)
2500-2999 grams 3,049,401 (18%) 2,737,600 (18%) 457 (23%) 41,941 (18%) 13,371 (19%) 32,043 (21%) 1,184 (27%) 7,561 (23%) 4,016 (23%) 813 (22%) 189,078 (28%) 19,683 (27%) 1,051 (26%) 603 (25%)
3000-3499 grams 6,628,254 (40%) 6,139,260 (40%) 792 (40%) 91,468 (39%) 27,707 (40%) 59,851 (39%) 1,773 (40%) 13,038 (39%) 7,025 (41%) 1,409 (38%) 256,129 (39%) 27,238 (38%) 1,627 (40%) 937 (39%)
3500-3999 grams 4,522,233 (27%) 4,257,048 (28%) 446 (23%) 66,114 (28%) 18,721 (27%) 38,451 (25%) 804 (18%) 7,526 (23%) 3,731 (22%) 935 (25%) 114,105 (17%) 13,052 (18%) 824 (20%) 476 (20%)
4000 grams and over 1,311,543 (8.0%) 1,243,492 (8.2%) 102 (5.2%) 20,813 (8.9%) 5,411 (7.8%) 11,333 (7.3%) 165 (3.7%) 2,109 (6.3%) 959 (5.6%) 240 (6.5%) 23,742 (3.6%) 2,856 (4.0%) 194 (4.8%) 127 (5.3%)

Individuals who smoked, regardless of their smoking behaviour, had, on average, lower levels of education compared to non-smokers. Additionally, individuals who smoked had a higher prevalences of participation in the WIC program. Non-smokers had the lowest percentages of pre-pregnancy hypertension, infant gestational age under 37 weeks, and low infant birth weight (1000–2499 grams). Among all individuals who smoke, individuals who only smoked pre-pregnancy had the lowest rates of pre-pregnancy hypertension, infant gestational age under 37 weeks, and low infant birth weight (Table 1).

Crude rates

In the overall population, the rate of SUID was 85.3 per 100,000 births. Compared with the rate of SUID among non-smokers (67.1 per 100,000 births), crude rates of SUID were higher in all maternal smoking behaviour groups, with light smokers who discontinuously smoked during their pregnancy (491.6 per 100,000 births) having the highest rates, followed by light continuous smokers (395.6 per 100,000 births), heavy continuous smokers (372.8 per 100,000 births), and individuals who only smoked during their second or third trimesters (351.7 per 100,000 births). Similar rates of SUID were observed among heavy smokers who discontinuously smoked during their pregnancy (292.5 per 100,000 births), individuals who only smoked during their first trimester (282.1 per 100,000 births), and light and heavy smokers who ceased smoking before their third trimester (light: 278.8 per 100,000 births; heavy: 259.35 per 100,000 births). Light and heavy smokers who only smoked during pre-pregnancy had the lowest rates of SUID (light: 188.2 per 100,000 births; heavy: 152.8 per 100,000 births) among all individuals that smoked (Table 2). Power calculations indicated that heavy and light categories for only smoking during the first trimester and only smoking during the second or third trimesters had insufficient sample sizes. Thus, heavy and light categories were combined, and dose responses were not examined for these maternal smoking behaviour categories.

Table 2. Unadjusted and adjusted associations between sudden unexpected infant death (SUID) by maternal smoking behaviour categories compared to non-smoking category, United States, 2017-2021.

Maternal smoking behaviour categories n/N Rate per 100,000 OR 95% CI aOR 95% CI
Nonsmoking 10209/15222196 67.1 Ref Ref Ref Ref
Continuous smoking (heavy) 2478/664741 372.8 5.58 5.33–5.82 2.81 2.67–2.94
Continuous smoking (light) 284/71790 395.6 5.92 5.25–6.65 2.47 2.19–2.78
Pre-pregnancy only (heavy) 358/234259 152.8 2.28 2.05–2.53 1.61 1.44–1.78
Pre-pregnancy only (light) 131/69620 188.2 2.81 2.35–3.32 1.77 1.48–2.10
Only 1st trimester smoking 16/5672 282.1 4.22 2.47–6.64 2.14 1.25–3.38
Only 2nd or 3rd trimester smoking 24/6824 351.7 5.26 3.42–7.66 2.30 1.50–3.36
Discontinuous smoking (heavy) 50/17096 292.5 4.37 3.27–5.70 2.29 1.72–3.00
Discontinuous smoking (light) 20/4067 491.6 7.36 4.58–11.10 3.27 2.03–4.93
Smoking cessation (heavy) 401/154618 259.4 3.87 3.50–4.28 2.30 2.07–2.54
Smoking cessation (light) 93/33362 278.8 4.17 3.37–5.08 2.00 1.62–2.44

OR, odds ratio; aOR, adjusted odds ratio; CI, confidence interval

Adjusted results

All maternal smoking behaviour categories  were compared to non-smokers (67.1 per 100,000 births). After adjusting for SES, maternal characteristics, and pregnancy characteristics, light smokers who discontinuously smoked during their pregnancy had the highest adjusted odds of SUID (491.6 per 100,000 births; aOR 3.27, 95% CI 2.03–4.93). They are followed by continuous heavy (372.8 per 100,000 births; aOR 2.81, 95% CI 2.67–2.94) and light smokers (395.6 per 100,000 births; aOR 2.47, 95% CI 2.19–2.78). Individuals who only smoked during their second or third trimesters (351.70 per 100,000 births; aOR 2.30, 95% CI 1.50–3.36) had similar odds of SUID with heavy smokers who smoked discontinuously throughout their pregnancy (292.5 per 100,000 births; aOR 2.29, 95% CI 1.72–3.00). However, higher odds of SUID were observed for individuals who only smoked during their second or third trimesters (351.70 per 100,000 births; aOR 2.30, 95% CI 1.50–3.36) compared to individuals who only smoked during their first trimester (282.09 per 100,000 births; aOR 2.14, 95% CI 1.25–3.38). Lastly, individuals who only smoked during pre-pregnancy had the lowest adjusted odds of SUID (light: 188.2 per 100,000 births; aOR 1.77, 95% CI 1.48–2.10; heavy: 152.8 per 100,000 births; aOR 1.61, 95% CI 1.44–1.78) (Table 2).

Among maternal smoking behaviour categories that were accessed for dose response, higher odds of SUID were observed among heavy smokers in individuals who continuously smoked (heavy: aOR 2.81, 95% CI 2.67–2.94; light: aOR 2.47, 95% CI 2.19–2.78) and among individuals who ceased smoking before their third trimester (heavy: aOR 2.30, 95% CI 2.07–2.54; light: aOR 2.00, 95% CI 1.62–2.44). For individuals that discontinuously smoked throughout their pregnancy (light: aOR 3.27, 95% CI 1.72–3.00; heavy: aOR 2.29, 95% CI 1.72–3.00) and for those who only smoked during pre-pregnancy (light: aOR 1.77, 95% CI 1.48–2.10; heavy: aOR 1.61, 95% CI 1.44–1.78), higher odds of SUID were observed among light smokers. However, CI overlapped for heavy and light smokers in every maternal smoking behaviour category (Fig 2).

Fig 2. Forrest plot of unadjusted and adjusted odds ratios of association between SUID by maternal smoking behaviour categories compared to non-smoking category, United States, 2017-2021.

Fig 2

Sensitivity analysis

Due to computation limitations, mediation analyses on birth weight and gestational age were only conducted for the continuous smoking category using a randomly generated subset of 500,000 samples. Furthermore, due to conversion issues, models used for mediation analyses needed to reduce model dimensionality. Therefore, maternal education, maternal age, number of prenatal visits, and payment method were excluded from the mediation model.

For gestational age, the OR for the NIE of continuous smoking throughout pregnancy on SUID through gestational age was insignificant (β = 1.01, 95% CI 0.99–1.03, p = 0.28). OR for NDE of continuous smoking throughout pregnancy on SUID was β = 2.34 (95% CI 1.68–3.01, p < 0.01), and OR for CDE was β = 2.35 (95% CI 1.62–3.08, p < 0.01). OR for the total effect of continuous smoking throughout pregnancy on SUID was β = 2.37 (95% CI 1.70–3.03, p < 0.01), with 1.71% (95% CI −1.44–4.85, p = 0.29) of the effect mediated by gestational age.

For infant birth weight, OR for NIE of continuous smoking throughout pregnancy on SUID through infant birth weight was insignificant (β = 1.04, 95% CI 0.99–1.08, p = 0.10). OR for NDE was β = 2.25 (95% CI 1.59–2.90, p < 0.01) and OR for CDE was β = 2.24 (95% CI 2.94–3.48, p < 0.01). The OR for the total effect of continuous smoking throughout pregnancy on SUID was β = 2.32 (95% CI 1.67–2.99, p < 0.01), with 6.28% (95% CI −1.30–13.87, p = 0.10) of the effect mediated by infant birth weight.

Discussion

This population-based, retrospective cohort study of live births in the US from 2017 to 2021 revealed significant associations between maternal smoking behaviour and SUID. After adjusting for these socio-economic disparities as well as key pregnancy and infant factors, we observed the highest SUID rates among continuous smokers (heavy and light). While discontinuous light smokers appeared to have the highest point estimate, the wide confidence interval suggests greater uncertainty around this estimate. Importantly, the confidence interval overlaps with all other smoking behaviour categories, indicating that the apparent difference between these groups may not be statistically meaningful. Additionally, we saw a trend suggesting higher odds of SUID among individuals smoking later in pregnancy. Sensitivity analyses found minimal mediation by gestational age and birth weight. These findings support our hypothesis that all smoking behaviours would have increased odds of SUID, with continuous smoking having the highest. However, no differences were observed between heavy and light smokers for any category.

Our findings align with prior studies that consistently demonstrate any maternal smoking during pregnancy increases the risk of SUID [12,13]. This is consistent with existing theoretical positions emphasizing smoking's detrimental impact on fetal and infant health. However, unlike some previous studies that observed a clear dose-response relationship across all smoking categories, our study did not find significant dose-response associations in any smoking behaviours. This discrepancy may stem from our use of categorical analysis, which may lack the granularity of linear modelling approaches traditionally used in this context. Misclassification is also a concern, as “light” smokers in our study may include individuals with smoking habits near the threshold of 20 cigarettes per day, potentially diluting dose-response patterns. Unexpected results, such as higher odds of SUID among light smokers in certain categories, may also reflect unmeasured variables. For instance, the lack of detailed data on smoking behaviours prior to pregnancy limited our ability to fully account for cumulative exposure. The omission of detailed data on smoking behaviours prior to pregnancy could lead to an underestimation or overestimation of the true association between smoking and SUID, as the model may not accurately capture the cumulative effects of nicotine exposure.

Our results reinforce the need for public health interventions targeting maternal smoking cessation, especially early in pregnancy or before conception. By demonstrating that even intermittent or low intensity smoking increases SUID risk, our study highlights the importance of framing any smoking during pregnancy as harmful. Based on our findings, smoking cessation prior to pregnancy could reduce the risk of SUID by 20%. Thus, early interventions, such as integrating smoking cessation counselling into prenatal care or WIC programs, could have significant public health benefits [26,27]. For instance, leveraging WIC participation as an opportunity for smoking cessation education could help address the socioeconomic disparities linked to smoking behaviours [28]. Furthermore, these findings highlight the need to reframe public health messaging around smoking during pregnancy. Educational campaigns should emphasize that cessation at any point reduces risk, but quitting earlier offers the most protective benefits. Policymakers could enhance access to smoking cessation resources, such as subsidized nicotine replacement therapies, especially for high-risk populations [29,30]. These findings also challenge healthcare providers and policymakers to address socioeconomic and behavioural factors that sustain smoking during pregnancy, implementing multi-faceted strategies to address SUID.

This study has several strengths. First, by differentiating between light and heavy smoking, continuous and discontinuous smoking, and timing of smoking during pregnancy, the study captured important variations in exposure. Additionally, this study adjusted for a comprehensive range of confounders, including socioeconomic factors, maternal health conditions, and pregnancy characteristics. Lastly, sensitivity analyses examined gestational age and infant birth weight as potential mediators, which provided valuable insights into the pathways linking maternal smoking to SUID. However, several limitations still exist. First, the study lacked data on maternal smoking behaviours prior to pregnancy, preventing the examination of cumulative tobacco exposure and its long-term effects on SUID. Additionally, data on alcohol or other substance use, which may interact with smoking, were unavailable. Lastly, sensitivity analyses were limited to a subset of continuously smoking individuals due to computation constraints, and non-bootstrap confidence intervals may affect the robustness of some estimates. Although the study made significant efforts to mitigate potential biases through confounder adjustment, the potential for residual confounding remains, particularly given the complex interplay of factors influencing SUID.

Despite these limitations, the study provides a valuable contribution to the literature by utilizing large-scale, nationally representative data and employing detailed categorizations of smoking behaviours. The findings from this study open several avenues for future research to better understand and address the relationship between maternal smoking and SUID. Future studies should examine the long-term impact of maternal smoking habits prior to pregnancy and the impact of changes in these habits during pregnancy on SUID outcomes. Additionally, studies should incorporate data on alcohol and other substance use, as well as potential interactions between these factors and smoking, to provide a more comprehensive understanding of their combined effects. Finally, investigating the complex interplay of socioeconomic, environmental, and biological factors through interdisciplinary approaches may help address residual confounding and uncover novel pathways influencing SUID risk. These efforts would strengthen the evidence base and inform targeted interventions to reduce SUID incidence.

Supporting information

S1 Appendix. DAG of maternal smoking behaviour and SUID.

(DOCX)

pone.0344554.s001.docx (117.4KB, docx)
S2 Table. Additional Demographic and maternal smoking behaviours of individuals with live births in the United States, 2017–2021.

(DOCX)

pone.0344554.s002.docx (33.5KB, docx)
S3 Appendix. Smoking trend among individuals with live birth in the U.S. from 2017 to 2021.

(DOCX)

pone.0344554.s003.docx (38.4KB, docx)
S4 Appendix. SUID trend among individuals with live birth in the U.S. from 2017 to 2021.

(DOCX)

pone.0344554.s004.docx (38.4KB, docx)
S5 Appendix. STROBE Statement Checklist of items that should be included in reports of cohort studies.

(DOC)

pone.0344554.s005.doc (79.5KB, doc)

Acknowledgments

We want to acknowledge the HRM 760: Applied Epidemiological Methods in Secondary Analysis course at McMaster University for the inception of this project, and the Perinatal Epidemiological Research Lab at McMaster University for its continual support.

Data Availability

All data are available at Centers for Disease Control and Prevention (CDC) specifically Period/Cohort Linked Birth-Infant Death Data Files. Accessed via URL: https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Kellams A, Feldman-Winter L. Sudden unexpected infant death. Clin Perinatol. 2021;48(3):619–30. doi: 10.1016/j.clp.2021.05.010 [DOI] [PubMed] [Google Scholar]
  • 2.Matthews TJ, MacDorman MF, Thoma ME. Infant mortality statistics from the 2013 period linked birth/infant death data set. Natl Vital Stat Rep. 2015;64(9):1–30. [PubMed] [Google Scholar]
  • 3.Shapiro-Mendoza CK, Parks S, Lambert AE. The epidemiology of sudden infant death syndrome and sudden unexpected infant deaths: diagnostic shift and other temporal changes. In: Duncan JR, Byard RW, eds. SIDS sudden infant and early childhood death: the past, the present and the future. Adelaide (AU): University of Adelaide Press; 2018. [PubMed] [Google Scholar]
  • 4.Centers for Disease Control and Prevention. Data and statistics for SUID and SIDS. Centers for Disease Control and Prevention. 2024. Accessed 2024 November 20. https://www.cdc.gov/sudden-infant-death/data-research/data/index.html
  • 5.Wolf ER, Rivara FP, Sen A, Woolf SH. Sudden unexpected infant death and disparities in infant mortality in the US, 1999-2022. JAMA Pediatr. 2025;179(3):344–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Blackburn CM, Bonas S, Spencer NJ, Coe CJ, Dolan A, Moy R. Parental smoking and passive smoking in infants: fathers matter too. Health Educ Res. 2005;20(2):185–94. doi: 10.1093/her/cyg117 [DOI] [PubMed] [Google Scholar]
  • 7.Merritt TA, Philips R, Armstrong S, Mazela J, Gadzinowski J. When you smoke your baby smokes: advancing maternal and child health through an academic alliance to improve health of mothers and their infants. Przegl Lek. 2010;67(10):821–3. [PubMed] [Google Scholar]
  • 8.Mitchell EA, Ford RP, Stewart AW, Taylor BJ, Becroft DM, Thompson JM, et al. Smoking and the sudden infant death syndrome. Pediatrics. 1993;91(5):893–6. doi: 10.1542/peds.91.5.893 [DOI] [PubMed] [Google Scholar]
  • 9.Mitchell EA, Thompson JM, Zuccollo J, MacFarlane M, Taylor B, Elder D, et al. The combination of bed sharing and maternal smoking leads to a greatly increased risk of sudden unexpected death in infancy: the New Zealand SUDI Nationwide Case Control Study. N Z Med J. 2017;130(1456):52–64. [PubMed] [Google Scholar]
  • 10.Hauck FR, Blackstone SR. Maternal smoking, alcohol and recreational drug use and the risk of SIDS among a US urban black population. Front Pediatr. 2022;10:809966. doi: 10.3389/fped.2022.809966 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Vivekanandarajah A, Nelson ME, Kinney HC, Elliott AJ, Folkerth RD, Tran H, et al. Nicotinic receptors in the brainstem ascending arousal system in SIDS with analysis of pre-natal exposures to maternal smoking and alcohol in high-risk populations of the safe passage study. Front Neurol. 2021;12:636668. doi: 10.3389/fneur.2021.636668 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.O’Leary CM, Jacoby PJ, Bartu A, D’Antoine H, Bower C. Maternal alcohol use and sudden infant death syndrome and infant mortality excluding SIDS. Pediatrics. 2013;131(3):e770-8. doi: 10.1542/peds.2012-1907 [DOI] [PubMed] [Google Scholar]
  • 13.Webb RT, Wicks S, Dalman C, Pickles AR, Appleby L, Mortensen PB, et al. Influence of environmental factors in higher risk of sudden infant death syndrome linked with parental mental illness. Arch Gen Psychiatry. 2010;67(1):69–77. doi: 10.1001/archgenpsychiatry.2009.172 [DOI] [PubMed] [Google Scholar]
  • 14.Van Nguyen JM, Abenhaim HA. Sudden infant death syndrome: review for the obstetric care provider. Am J Perinatol. 2013;30(9):703–14. doi: 10.1055/s-0032-1331035 [DOI] [PubMed] [Google Scholar]
  • 15.Anderson TM, Lavista Ferres JM, Ren SY, Moon RY, Goldstein RD, Ramirez J-M, et al. Maternal smoking before and during pregnancy and the risk of sudden unexpected infant death. Pediatrics. 2019;143(4):e20183325. doi: 10.1542/peds.2018-3325 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ostfeld BM, Schwartz-Soicher O, Reichman NE, Hegyi T. Racial differences in the impact of maternal smoking on sudden unexpected infant death. J Perinatol. 2023;43(3):345–9. doi: 10.1038/s41372-022-01516-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bandoli G, Baer RJ, Owen M, Kiernan E, Jelliffe-Pawlowski L, Kingsmore S, et al. Maternal, infant, and environmental risk factors for sudden unexpected infant deaths: results from a large, administrative cohort. J Matern Fetal Neonatal Med. 2022;35(25):8998–9005. doi: 10.1080/14767058.2021.2008899 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tanner D, Ramirez J-M, Weeks WB, Lavista Ferres JM, Mitchell EA. Maternal obesity and risk of sudden unexpected infant death. JAMA Pediatr. 2024;178(9):906–13. doi: 10.1001/jamapediatrics.2024.2455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Centers for Disease Control and Prevention. Data access - vital statistics online. 2024. Accessed 2024 October 23. https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm
  • 20.Glass HC, Costarino AT, Stayer SA, Brett CM, Cladis F, Davis PJ. Outcomes for extremely premature infants. Anesth Analg. 2015;120(6):1337–51. doi: 10.1213/ANE.0000000000000705 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chang JT, Anic GM, Rostron BL, Tanwar M, Chang CM. Cigarette smoking reduction and health risks: a systematic review and meta-analysis. Nicotine Tob Res. 2021;23(4):635–42. doi: 10.1093/ntr/ntaa156 [DOI] [PubMed] [Google Scholar]
  • 22.Di H-K, Gan Y, Lu K, Wang C, Zhu Y, Meng X, et al. Maternal smoking status during pregnancy and low birth weight in offspring: systematic review and meta-analysis of 55 cohort studies published from 1986 to 2020. World J Pediatr. 2022;18(3):176–85. doi: 10.1007/s12519-021-00501-5 [DOI] [PubMed] [Google Scholar]
  • 23.Nawa N, Garrison-Desany HM, Kim Y, Ji Y, Hong X, Wang G, et al. Maternal persistent marijuana use and cigarette smoking are independently associated with shorter gestational age. Paediatr Perinat Epidemiol. 2020;34(6):696–705. doi: 10.1111/ppe.12686 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Goodstein MH, Stewart DL, Keels EL, Moon RY, Committee on fetus and newborn, task force on sudden infant death syndrome. Transition to a safe home sleep environment for the NICU patient. Pediatrics. 2021;148(1):e2021052045. doi: 10.1542/peds.2021-052045 [DOI] [PubMed] [Google Scholar]
  • 25.Armstrong AW, Foley P, Liu Y, Miller M, Teneralli RE, Bewley A, et al. Direct and indirect effect of guselkumab on anxiety, depression, and quality of life in patients with moderate-to-severe plaque psoriasis: a mediation analysis. Dermatol Ther (Heidelb). 2024;14(9):2577–89. doi: 10.1007/s13555-024-01250-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Olaiya O, Sharma AJ, Tong VT, Dee D, Quinn C, Agaku IT, et al. Impact of the 5As brief counseling on smoking cessation among pregnant clients of Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) clinics in Ohio. Prev Med. 2015;81:438–43. doi: 10.1016/j.ypmed.2015.10.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Matkin W, Ordóñez-Mena JM, Hartmann-Boyce J. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2019;5(5):CD002850. doi: 10.1002/14651858.CD002850.pub4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Goldstein B, Steiner A, VanderWielen L, Bennett K, Tomcho M. Integration of special supplemental nutrition program for women, infants, and children (WIC) in primary care settings. J Commun Health. 2024;49(2):330–7. doi: 10.1007/s10900-023-01287-5 [DOI] [PubMed] [Google Scholar]
  • 29.Williams JH, Jones TE. Smoking cessation post-discharge following nicotine replacement therapy use during an inpatient admission. Intern Med J. 2012;42(2):154–9. doi: 10.1111/j.1445-5994.2011.02442.x [DOI] [PubMed] [Google Scholar]
  • 30.Keller KG, Lach HW. Nurse counseling as part of a multicomponent tobacco treatment intervention: an integrative review. J Addict Nurs. 2020;31(3):161–79. doi: 10.1097/JAN.0000000000000347 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Malshani Pathirathna

15 Dec 2025

-->PONE-D-25-50358-->-->Maternal Smoking Behaviour During Pregnancy and the Association of Sudden Unexpected Infant Death (SUID): A Cohort Study-->-->PLOS One

Dear Dr. Hudson,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 29 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

-->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols ..

We look forward to receiving your revised manuscript.

Kind regards,

Malshani Lakshika Pathirathna, PhD

Academic Editor

PLOS One

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex

3. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: The work presented in this manuscript is important and it is very well written. However, the title does not indicate the study setting and no indication of the type of study. Other than that, I do not believe that any editing is required except, may be in formatting and removing the title, sub title levels given within parenthesis and the numbering and titles of figures.

Reviewer #2: This is a well-written clear manuscript that adds to the literature by incorporating 'heaviness' and 'timing' of smoking during pregnancy into the SUID literature. The only issues I have with the paper are 1. there IS a paper examining the relationship between maternal obesity and SUID (https://pubmed.ncbi.nlm.nih.gov/39073792/)...Seemingly, obesity (which is available in the CDC dataset) should be a covariate. and 2. the authors should re-order table 2, from highest to lowest aOR, and then describe findings in the results section (and abstract) going down from higherst to lowest. As it is, the jumping around makes it confusing to a reader. Similarly, reorient the forest plot in the same way.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy .-->.-->

Reviewer #1: No

Reviewer #2: Yes: William B Weeks, MD, PhD, MBAWilliam B Weeks, MD, PhD, MBA

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

-->

PLoS One. 2026 Mar 30;21(3):e0344554. doi: 10.1371/journal.pone.0344554.r002

Author response to Decision Letter 1


25 Jan 2026

Reviewer #1

Comment 1. The work presented in this manuscript is important and it is very well written. However, the title does not indicate the study setting and no indication of the type of study. Other than that, I do not believe that any editing is required except, may be in formatting and removing the title, sub title levels given within parenthesis and the numbering and titles of figures.

Response: Thank you. We have indicated the study setting and study type into the long title, changing it to “Maternal Smoking Behaviour During Pregnancy and the Association of Sudden Unexpected Infant Death (SUID): A Retrospective Cohort Study of Births in the United States from 2017-2021”. We have also changed the heading levels formats, and added an acknowledgement section (lines 301-304) and supporting information section (lines 406-414). Lastly, we referred to the PLOS One submission guide to ensure that our figures, table numbers, titles, and citations fit the criteria.

Reviewer #2

Comment 1. This is a well-written clear manuscript that adds to the literature by incorporating 'heaviness' and 'timing' of smoking during pregnancy into the SUID literature.

Response: Thank you.

Comment 2. There IS a paper examining the relationship between maternal obesity and SUID (https://pubmed.ncbi.nlm.nih.gov/39073792/)...Seemingly, obesity (which is available in the CDC dataset) should be a covariate.

Response: Thank you for pointing out the lack of maternal obesity indicated as covariate despite it being included in our analysis. We have indicated pregnancy body mass index as a covariate in our manuscript (lines 121), have added its distribution into the S2 Table, and added reference #18: Tanner D, et al. Maternal obesity and risk of sudden unexpected infant death. JAMA Pediatrics. 2024;178(9):906-913. doi: 10.1001/jamapediatrics.2024.2455.

Comment 3. The authors should re-order table 2, from highest to lowest aOR, and then describe findings in the results section (and abstract) going down from highest to lowest. As it is, the jumping around makes it confusing to a reader. Similarly, reorient the forest plot in the same way.

Response: We have reordered our findings in Crude Rate (line 168-177) and Adjusted Results (line 191-199, line 204-207 going from highest to lowest. However, regarding the forest plot and Table 2, while we understand the reviewer’s point, given that our study seeks to examine duration since smoking cessation, presenting smoking levels in a sequential way will more clearly show timing of smoking cessation and its relationship and trends with SUID. Additionally, keeping heavy and light smoker together for each smoking category will make it easier to evaluate dose response.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0344554.s006.docx (19.4KB, docx)

Decision Letter 1

Malshani Pathirathna

24 Feb 2026

Maternal smoking behaviour during pregnancy and the association of Sudden Unexpected Infant Death (SUID): A retrospective cohort study of births in the United States from 2017-2021

PONE-D-25-50358R1

Dear Dr. Kiki Hudson,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support ..

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Malshani Lakshika Pathirathna, PhD

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: (No Response)

Reviewer #2: In figure 2, the y-axis legend should read "Odds Ratio" not "Odds Ration".....I'm now typing to make the minimum character count requirment.

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy .-->.-->

Reviewer #1: No

Reviewer #2: Yes: William B WeeksWilliam B Weeks

**********

Acceptance letter

Malshani Pathirathna

PONE-D-25-50358R1

PLOS One

Dear Dr. Hudson,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Malshani Lakshika Pathirathna

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. DAG of maternal smoking behaviour and SUID.

    (DOCX)

    pone.0344554.s001.docx (117.4KB, docx)
    S2 Table. Additional Demographic and maternal smoking behaviours of individuals with live births in the United States, 2017–2021.

    (DOCX)

    pone.0344554.s002.docx (33.5KB, docx)
    S3 Appendix. Smoking trend among individuals with live birth in the U.S. from 2017 to 2021.

    (DOCX)

    pone.0344554.s003.docx (38.4KB, docx)
    S4 Appendix. SUID trend among individuals with live birth in the U.S. from 2017 to 2021.

    (DOCX)

    pone.0344554.s004.docx (38.4KB, docx)
    S5 Appendix. STROBE Statement Checklist of items that should be included in reports of cohort studies.

    (DOC)

    pone.0344554.s005.doc (79.5KB, doc)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0344554.s006.docx (19.4KB, docx)

    Data Availability Statement

    All data are available at Centers for Disease Control and Prevention (CDC) specifically Period/Cohort Linked Birth-Infant Death Data Files. Accessed via URL: https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES